Browse resources

Disease: Rotavirus

Total results with these characteristics: 241

Page 5 of 10  
‹ prev.
2
3
4
5
6
7
8
next ›

A Multi-Center, Qualitative Assessment of Pediatrician and Maternal Perspectives on Rotavirus Vaccines and the Detection of Porcine circovirus

This article, published in BMC Pediatrics, reports on research that evaluated perceptions among physicians and mothers after the 2011 finding of DNA fragments of Porcine circovirus in rotavirus vaccines. Physicians expressed that the finding was of …

Author: Payne DC, Humiston S, Opel D, et al.

Published: 2011

On a Multicenter Assessment of Rotavirus Disease in Europe

This editorial summarizes the characteristics of studies on rotavirus epidemiology and disease burden in Europe, published in a special supplement to the Journal of Infectious Diseases.

Author: Matson D

Published: 2007

Overview of RotaTeq® Human-bovine Reassortant Rotavirus Vaccine

This presentation from an informal consultation on proposed World Health Organization guidelines to assure quality, safety, and efficacy of live, attenuated rotavirus vaccines reported on studies of the safety and efficacy of the RotaTeq® …

Author: Shaw A, Heaton P

Published: 2005

PATH Rotavirus Advocacy and Communications Toolkit

This toolkit was developed to help increase awareness of the burden of rotavirus disease and the power of rotavirus vaccines to prevent childhood deaths and hospitalizations. It contains key messages, fact sheets, country introduction maps, and …

Author: PATH

Performance of Rotavirus Vaccines in Developed and Developing Countries

This article, published in Human Vaccines, provides a review of published data on previous candidate rotavirus vaccines and vaccines in current use, with emphasis on their performance in developed versus developing countries. In developed countries, …

Author: Jiang V, Jiang B, Tate J, Parashar UD, Patel MM

Published: 2010

Persisting Consequences of Intestinal Infection

This issue of the Old Herborn University Seminar Monograph provides a summary of the discussions at an expert workshop hosted by the Old Herborn University Foundation in June 2013. The discussions were held to assess the experts' epidemiological and …

Author: Heidt PJ, Lang D, Riddle MS, Walker RI, Rusch V, eds.

Published: 2014

The Pink Book—Epidemiology and Prevention of Vaccine-Preventable Diseases

This book provides physicians, nurses, nurse practitioners, physician assistants, pharmacists, and others with the most comprehensive information on vaccine-preventable diseases. In addition to chapters on more general vaccine-related topics, it …

Author: US Centers for Disease Control and Prevention

Published: 2012

Pneumonia and Diarrhea Progress Report 2013

This report evaluates the 15 countries with the highest number of child deaths from pneumonia and diarrhea and reports on their progress in implementing evidence-based interventions that are outlined in the Global Action Plan for the Prevention and …

Author: International Vaccine Access Center

Published: 2013

Pneumonia and Diarrhoea: Tackling the Deadliest Diseases for the World’s Poorest Children

This report focuses on the huge potential to narrow the child survival gap between the richest and the poorest by focusing on pneumonia and diarrhea—the two primary killers of children under the age of five. It includes a review of the current …

Author: United Nations Children's Fund

Published: 2012

Postmarketing Monitoring of Intussusception After RotaTeq Vaccination-United States, February 1, 2006 - February 15, 2007

This article, published in Morbidity and Mortality Weekly Report, summarizes the Advisory Committee on Immunization Practices review of post-marketing safety surveillance data on RotaTeq®, the rotavirus vaccine by Merck & Co., Inc. The …

Author: US Centers for Disease Control and Prevention

Published: 2007

Post-Marketing Surveillance of Rotavirus Vaccine Safety

This manual provides a review of current knowledge related to the safety of rotavirus vaccine and suggests approaches for monitoring safety after vaccine introduction in a country.

Author: World Health Organization

Published: 2009

Potential Cost-Effectiveness of Vaccination for Rotavirus Gastroenteritis in Eight Latin American and Caribbean Countries

Investigators developed a model using epidemiological evidence, country-specific cost estimates, and vaccine efficacy data to estimate the cost-effectiveness of rotavirus vaccination and determined that it would reduce health care expenses and …

Author: Rheingans R, Constenla D, Antil L, Innis B, Breuer T

Published: 2007

Potential Intussusception Risk Versus Benefits of Rotavirus Vaccination in the United States

International data show a low-level increased risk of intussusception associated with rotavirus vaccination. This article, published in the Pediatric Infectious Disease Journal, reports on a study that compared potential vaccine-associated …

Author: Rishi D, Cortese M, Meltzer MI, et al.

Published: 2013

Prevention of Rotavirus Gastroenteritis Among Infants and Children: Recommendations of the Advisory Committee on Immunization Practices

This report, published in Morbidity and Mortality Weekly Report, provides background on the development of RotaTeq®, Merck's vaccine against rotavirus, and recommendations for its use in the prevention of rotavirus through immunization.

Author: US Centers for Disease Control and Prevention

Published: 2006

Prevention of Rotavirus Gastroenteritis in Infants and Children: Rotavirus Vaccine Safety, Efficacy, and Potential Impact of Vaccines

This article, published in Biologics: Targets & Therapy, provides a comprehensive review of current rotavirus vaccines, summarizing studies on their safety and efficacy, as well as special considerations that may inform future research studies. …

Author: Chandran A, Fitzwater S, Zhen A, Santosham M

Published: 2010

Procurement and Pricing of New Vaccines for Developing Countries

Several vaccines that have come to market, including the rotavirus, pneumococcal conjugate, and human papillomavirus vaccines, have the potential to bring large public health benefits to developing countries. This eight-page policy brief explains …

Author: International AIDS Vaccine Initiative

Published: 2008

Projected Health and Economic Impact of Rotavirus Vaccination in GAVI-Eligible Countries: 2011–2030

This article, published in Vaccine, projects the cost-effectiveness and health impact of rotavirus vaccines in countries eligible for support from the GAVI Alliance. The authors used a decision-analytic model to project the health outcomes and …

Author: Atherly DE, Lewis KDC, Tate J, Parashar UD, Rheingans RD

Published: 2012

Projected Health Benefits and Costs of Pneumococcal and Rotavirus Vaccination in Uganda

The authors of this article, published in Vaccine, determined the impact and cost-effectiveness of pneumococcal and rotavirus vaccination programs among children younge than five years of age in Uganda from the public health system perspective. They …

Author: Tate JE, Kisakye A, Mugyenyi P, Kizza D, Odiit A, Braka F

Published: 2011

Projected Impact and Cost-Effectiveness of a Rotavirus Vaccination Program in India, 2008

The authors of this article, published in Clinical Infectious Diseases, aimed to determine the potential impact and cost-effectiveness of a national rotavirus vaccination program in India. They compared the national rotavirus disease and cost burden …

Author: Esposito DH, Tate JE, Kang G, Parashar UD

Published: 2011

Projecting the Effectiveness of RotaTeq® Against Rotavirus-Related Hospitalizations and Deaths in Six Asian Countries

This article, published in Human Vaccines, describes the projected effectiveness of RotaTeq®, which is an oral pentavalent rotavirus vaccine (RV5), against rotavirus gastroenteritis (RGE)-related hospitalizations and deaths in six Asian …

Author: El Khoury AC, Mast TC, Ciarlet M, Markson LE, Goveia MG

Published: 2011

Protecting Aluminum-Adjuvanted Vaccines From Freeze Damage

This fact sheet describes how PATH developed a low-cost and straightforward technology for protecting aluminum-adjuvanted liquid vaccines from the irreversible damage that results from freezing. Many current vaccines of importance to global …

Author: PATH

Published: 2012

Protecting Child Health for a Promising Future

This fact sheet provides a snapshot of PATH's programs that tackle the leading causes of childhood illness and death: pneumonia, diarrheal disease, and malaria. It profiles PATH's work on new and innovative vaccines, medicines, diagnostics, and …

Author: PATH

Published: 2012

Protecting Children From Diarrheal Disease: PATH Takes a Comprehensive Approach to Combating This Leading Cause of Child Deaths

This fact sheet provides an overview of PATH's work, including vaccine development and introduction, in protecting children from diarrheal disease.

Author: PATH

Published: 2011

Protective Association Between Rotavirus Vaccination and Childhood Seizures in the Year Following Vaccination in US Children

This article, published in Clinical Infectious Diseases, describes a review of data from 250,000 children born in the United States between March 2006—when rotavirus vaccines were introduced in the United States—and November 2009 for incidences …

Author: Payne DC, Baggs J, Zerr DM, et al.

Published: 2013

ProVac Rotavirus e-Learning Course

This online course is a practical tool designed to aid health care administrators in making evidence-based decisions regarding rotavirus vaccine introduction into national immunization programs. The module provides training on topics ranging from …

Author: Pan American Health Organization

Page 5 of 10  
‹ prev.
2
3
4
5
6
7
8
next ›